Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hosted in the seminar room and Zoom. To join online, please use the Zoom link below: https://zoom.us/j/94457342362?pwd=bCtoSXlaSjRNejBMaXluSTMwVWdVQT09 Meeting ID: 944 5734 2362 Passcode: 051588

Persisting cognitive impairments, including 'brain fog', afflict some people after COVID-19 infection. Its cause is unknown, but there are a range of hypotheses. Paul will present the latest evidence about the magnitude and duration of risk, before Max summarises the findings from a prospective cohort study of 1837 people hospitalised for COVID-19 infection. Results from the study reveal two acute biomarker profiles that independently predict risk of subsequent cognitive impairment. Both profiles suggest coagulopathy ('microclots') at the time of infection as an underlying mechanism, with one pointing to the brain and the other pointing to the lungs as a possible location of clots. A complementary study using health records suggest that one profile is specific to COVID-19, whereas the other may be relevant to cognitive impairment more generally. Strengths and limitations of the data will be discussed.

Hosted in the seminar room and Zoom. To join online, please use the Zoom link below:

https://zoom.us/j/94457342362?pwd=bCtoSXlaSjRNejBMaXluSTMwVWdVQT09
Meeting ID: 944 5734 2362
Passcode: 051588